DRKS00009869招募中不适用
Therapeutic Drug Monitoring in tuberculosis patients. Setup and optimisation of therapeutic drug monitoring at the Research Center Borstel
Medizinische Klinik des Foschungszentrums Borstel0 个研究点目标入组 20 人开始时间: 2016年1月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •pan-susceptible, MDR and XDR Tuberculosis
排除标准
- •Currently pregnant or breastfeeding, participation/enrollement not feasible according to a physician, unable to provide informed consent, no consent obtained
研究者
相似试验
招募中
4 期
Therapeutic drug monitoring in tocilizumab-treated rheumatoid arthritis patients: Pilot study of a double-blind randomised controlled trialrheuma10003816rheumatoid arthritisNL-OMON44574Amsterdam Rheumatology and immunology Center | Reade30
尚未招募
不适用
latent TB in healthcare workersCTRI/2018/11/016432TMA Pai endowment chair Manipal Academy Of Higher Education
已完成
不适用
The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot StudyActive TuberculosisNCT02042261Thomas Schon38
已完成
不适用
The effect of monitoring of tobramycin levels in blood in patients with cystic fibrosis.Cystic fibrosisNL-OMON20263AMC35
尚未招募
4 期
Test and Treat to End Tuberculosis (TB): A screening and treatment study for children and adults with Latent Tuberculosis Infection (LTBI)tuberculosisatent Tuberculosis InfectionLatent Tuberculosis InfectionRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesPublic Health - EpidemiologyPublic Health - Health service researchACTRN12622000115730Woolcock Institute of Medical Research208,000